| Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics … P Horak, M Griffith, AM Danos, BA Pitel, S Madhavan, X Liu, C Chow, ... Genetics in Medicine 24 (5), 986-998, 2022 | 84 | 2022 |
| OncoKids: a comprehensive next-generation sequencing panel for pediatric malignancies MC Hiemenz, DG Ostrow, TM Busse, J Buckley, DT Maglinte, M Bootwalla, ... The Journal of Molecular Diagnostics 20 (6), 765-776, 2018 | 67 | 2018 |
| Human A53T α-synuclein causes reversible deficits in mitochondrial function and dynamics in primary mouse cortical neurons L Li, S Nadanaciva, Z Berger, W Shen, K Paumier, J Schwartz, K Mou, ... PloS one 8 (12), e85815, 2013 | 62 | 2013 |
| Carbonic anhydrase related protein 8 mutation results in aberrant synaptic morphology and excitatory synaptic function in the cerebellum M Hirasawa, X Xu, RB Trask, TP Maddatu, BA Johnson, JK Naggert, ... Molecular and Cellular Neuroscience 35 (1), 161-170, 2007 | 56 | 2007 |
| Mutation in archain 1, a subunit of COPI coatomer complex, causes diluted coat color and Purkinje cell degeneration X Xu, R Kedlaya, H Higuchi, S Ikeda, MJ Justice, V Setaluri, A Ikeda PLoS genetics 6 (5), e1000956, 2010 | 55 | 2010 |
| Assessing copy number aberrations and copy neutral loss of heterozygosity across the genome as best practice: An evidence based review of clinical utility from the cancer … R Kanagal-Shamanna, JC Hodge, T Tucker, S Shetty, A Yenamandra, ... Cancer genetics 228, 197-217, 2018 | 40 | 2018 |
| The advantage of using SNP array in clinical testing for hematological malignancies—a comparative study of three genetic testing methods X Xu, EB Johnson, L Leverton, A Arthur, Q Watson, FL Chang, G Raca, ... Cancer genetics 206 (9-10), 317-326, 2013 | 37 | 2013 |
| Guiding the global evolution of cytogenetic testing for hematologic malignancies YMN Akkari, LB Baughn, AM Dubuc, AC Smith, M Mallo, P Dal Cin, ... Blood, The Journal of the American Society of Hematology 139 (15), 2273-2284, 2022 | 35 | 2022 |
| Assessing copy number abnormalities and copy-neutral loss-of-heterozygosity across the genome as best practice in diagnostic evaluation of acute myeloid leukemia: An evidence … X Xu, C Bryke, M Sukhanova, E Huxley, DP Dash, A Dixon-Mciver, ... Cancer genetics 228, 218-235, 2018 | 35 | 2018 |
| Concurrent detection of targeted copy number variants and mutations using a myeloid malignancy next generation sequencing panel allows comprehensive genetic analysis using a … W Shen, P Szankasi, M Sederberg, J Schumacher, KA Frizzell, EP Gee, ... British journal of haematology 173 (1), 49-58, 2016 | 29 | 2016 |
| Genome-wide copy number variation detection using NGS: data analysis and interpretation W Shen, P Szankasi, J Durtschi, TW Kelley, X Xu Tumor Profiling: Methods and Protocols, 113-124, 2019 | 17 | 2019 |
| Characterization of unusual iAMP21 B‐lymphoblastic leukemia (iAMP21‐ALL) from the Mayo Clinic and Children's Oncology Group A Koleilat, JB Smadbeck, CJ Zepeda‐Mendoza, CM Williamson, BA Pitel, ... Genes, Chromosomes and Cancer 61 (12), 710-719, 2022 | 14 | 2022 |
| CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase K Krysiak, AM Danos, J Saliba, JF McMichael, AC Coffman, S Kiwala, ... Nucleic acids research 51 (D1), D1230-D1241, 2023 | 12 | 2023 |
| Detection of genome-wide copy number variants in myeloid malignancies using next-generation sequencing W Shen, CN Paxton, P Szankasi, M Longhurst, JA Schumacher, ... Journal of Clinical Pathology 71 (4), 372-378, 2018 | 12 | 2018 |
| Detection of cryptic CCND1 rearrangements in mantle cell lymphoma by next generation sequencing K Polonis, MJ Schultz, H Olteanu, JB Smadbeck, SH Johnson, ... Annals of Diagnostic Pathology 46, 151533, 2020 | 10 | 2020 |
| Typical, atypical and cryptic t(15;17)(q24;q21) (PML::RARA) observed in acute promyelocytic leukemia: A retrospective review of 831 patients with concurrent chromosome … MF Gagnon, HE Berg, RG Meyer, WR Sukov, DL Van Dyke, RB Jenkins, ... Genes, Chromosomes and Cancer 61 (10), 629-634, 2022 | 9 | 2022 |
| Clinical utility of next generation sequencing to detect IGH/IL3 rearrangements [t (5; 14)(q31. 1; q32. 1)] in B-lymphoblastic leukemia/lymphoma AJ Guenzel, JB Smadbeck, CL Golden, CM Williamson, JCB Demasi, ... Annals of Diagnostic Pathology 53, 151761, 2021 | 9 | 2021 |
| Myeloid malignancies with 5q and 7q deletions are associated with extreme genomic complexity, biallelic TP53 variants, and very poor prognosis BA Pitel, N Sharma, C Zepeda-Mendoza, JB Smadbeck, KE Pearce, ... Blood cancer journal 11 (2), 18, 2021 | 9 | 2021 |
| Genomic Copy Number Analysis of HER2-Equivocal Breast Cancers KB Geiersbach, C Willmore-Payne, AV Pasi, CN Paxton, TL Werner, X Xu, ... American Journal of Clinical Pathology 146 (4), 439-447, 2016 | 9 | 2016 |
| Cryptic and atypical KMT2A‐USP2 and KMT2A‐USP8 rearrangements identified by mate pair sequencing in infant and childhood leukemia PR Blackburn, JB Smadbeck, I Znoyko, MR Webley, BA Pitel, G Vasmatzis, ... Genes, Chromosomes and Cancer 59 (7), 422-427, 2020 | 8 | 2020 |
